Clinical Nuclear Medicine · 2004 · 23 citations · 5 references
MedicineNeurologyOncologyNeuro-oncologyNeuroradiologyOncologic ImagingCentral Nervous System TumorsNeuro-oncologic ImagingNeuro-oncologic PathologyNeuro-oncology ImagingPeripheral Nerve Tumors18F-fluorodeoxyglucose ImagingFluorine-18 Fluorodeoxyglucose Positron Emission TomographyNeurofibromatosis Type 1Neurofibromatosis-associated TumorsPeripheral Nerve Tumor DiagnosisPeripheral Nerve Tumor HistopathologyPositron Emission Tomography DetectionTherapy Planning Imaging
Retroperitoneal malignant peripheral nerve sheath tumor (MPNST), a rare type of neurogenic tumor, was diagnosed in a 14-year-old girl with a history of neurofibromatosis type 1 (NF1). Immunochemistry demonstrated spindle cells positive for S-100 protein. The patient had multiple tumor recurrences and she was evaluated with serial F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET). A tumor in the right iliac wing showed increased FDG uptake on PET. FDG-PET played an important role in therapy planning and subsequent follow up. This case emphasizes the important role FDG-PET could play in the staging, restaging, and posttherapy follow up of MPNST.
5
Cytologic Features of Malignant Peripheral Nerve Sheath Tumor
José A. Jiménez‐Heffernan, Pilar López‐Ferrer, Blanca Vicandi et al. · Acta Cytologica · 1999 · 43 citations